MedTrace Logo

Effects of Prebiotics on GLP-1 in Type 2 Diabetes

NCT02569684 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2020-09-16

No results posted yet for this study

Summary

The aim of the study is to compare the effects of prebiotics versus placebo on blood concentrations of glucagon-like peptide-1 in subjects with diabetes type 2.

Conditions

  • Diabetes Type 2

Interventions

DIETARY_SUPPLEMENT

Prebiotic fibers: oligofructose and inulin

DIETARY_SUPPLEMENT

Maltodextrin

Sponsors & Collaborators

  • Norwegian Diabetes Association

    collaborator OTHER

  • Norwegian Extra Foundation for Health and Rehabilitation

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Anne-Marie Aas, PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-01-31
Completion
2019-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569684 on ClinicalTrials.gov